Quest Diagnostics, Inc’s recently made public that its Director Gregg Vicky B unloaded Company’s shares for reported $0.21 million on Feb 05 ’25. In the deal valued at $164.57 per share,1,250 shares were sold. As a result of this transaction, Gregg Vicky B now holds 16,867 shares worth roughly $ 2.85 million.
Then, DELANEY MARK E sold 403 shares, generating $66,214 in total proceeds. Upon selling the shares at $164.30, the SVP & Chief Commercial Officer now owns 4,624 shares.
Before that, DELANEY MARK E bought 403 shares. Quest Diagnostics, Inc shares valued at $66,214 were divested by the Officer at a price of $164.30 per share.
Leerink Partners upgraded its Quest Diagnostics, Inc [DGX] rating to an Outperform from a a Market perform in a research note published on January 06, 2025; the price target was increased to $174 from $169. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid December from “an Equal-weight” to “an Overweight”. Robert W. Baird revised its rating on October 23, 2024. It rated DGX as “an Outperform” which previously was an “a Neutral”.
Price Performance Review of DGX
On Friday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock jump 0.03% to $168.77. Over the last five days, the stock has gained 3.77%. Quest Diagnostics, Inc shares have risen nearly 11.87% since the year began. Nevertheless, the stocks have risen 32.00% over the past one year. While a 52-week high of $169.27 was reached on 02/14/25, a 52-week low of $123.30 was recorded on 01/16/25. SMA at 50 days reached $156.70, while 200 days put it at $150.55.
Levels Of Support And Resistance For DGX Stock
The 24-hour chart illustrates a support level at 167.49, which if violated will result in even more drops to 166.20. On the upside, there is a resistance level at 170.68. A further resistance level may holdings at 172.58. The Relative Strength Index (RSI) on the 14-day chart is 66.37, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.72, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 14.61%. Stochastics %K at 86.52% indicates the stock is a selling.
How much short interest is there in Quest Diagnostics, Inc?
A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2025-01-31, growing by 0.55 million shares to a total of 2.58 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-31 was 2.03 million shares. There was a rise of 21.24%, which implies that there is a positive sentiment for the stock.
